Cargando…
CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia
[Figure: see text]
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840233/ https://www.ncbi.nlm.nih.gov/pubmed/35500285 http://dx.doi.org/10.1182/bloodadvances.2021006810 |
| Sumario: | [Figure: see text] |
|---|